VYMDADA 80MG

About

Sacubitril/Valsartan, marketed as VYMDADA, is a combination medication comprising a neprilysin inhibitor (sacubitril) and an angiotensin receptor blocker (valsartan). It works by enhancing the protective neurohormonal systems through sacubitril, which inhibits the enzyme neprilysin, leading to increased levels of natriuretic peptides. Simultaneously, valsartan inhibits the harmful effects of the renin-angiotensin-aldosterone system (RAAS). This dual mechanism helps to reduce cardiac workload, improve cardiac function, and decrease fluid retention. It is primarily indicated for chronic heart failure with reduced ejection fraction, where it has demonstrated significant reductions in cardiovascular mortality and heart failure hospitalizations. The synergistic action of its components provides a more comprehensive approach to managing the complex pathophysiology of heart failure compared to traditional RAAS inhibitors alone, offering a vital therapeutic option for improving patient outcomes.

Uses

• Treatment of chronic heart failure with reduced ejection fraction.
• Reduction of cardiovascular death in heart failure patients.
• Reduction of heart failure hospitalizations.
• Improvement of symptoms and physical limitations associated with heart failure.

Directions For Use

Take this medication orally, usually twice daily, as prescribed by your doctor. It can be taken with or without food.

Benefits

• Significantly reduces risk of cardiovascular death.
• Decreases heart failure hospitalizations.
• Improves heart function and symptoms.
• Enhances natriuretic peptide levels.
• Blocks harmful effects of RAAS.
• Offers a comprehensive approach to heart failure management.

Side Effects

• Hypotension (low blood pressure)
• Hyperkalemia (high potassium levels)
• Renal impairment (kidney problems)
• Angioedema (swelling under the skin)
• Dizziness
• Cough
• Fatigue
• Nausea
• Diarrhea
• Headache
• Anemia
• Syncope (fainting)

Safety Measures

• Alcohol - Alcohol can exacerbate the hypotensive effects of this medication; use with caution and discuss with your doctor.
• Pregnancy - Contraindicated in pregnancy due to potential fetal harm; use effective contraception.
• Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk and harm the infant.
• Liver - Use with caution in patients with severe hepatic impairment; dose adjustment may be necessary.
• Kidney - Requires careful monitoring of renal function; dose adjustment may be needed in moderate to severe impairment.
• Lung - Generally safe for use in patients with lung conditions, but monitor for angioedema affecting airways.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.